US Federal Reserve hikes, decades-high inflation and COVID-19 lockdowns in China are only adding to investor bets that Southeast Asia’s stock markets could be one of the best places to park their money right now.
Buyers are touting an economic reopening and the region’s attraction as a hedge against higher commodity prices, which is helping the MSCI ASEAN Index break out of a three-year relative downtrend versus its global peer.
Foreign funds have been net buying Southeast Asia shares every month of this year, with total inflows of US$10 billion so far, data showed.
“There has definitely been a pickup in interest in ASEAN,” said Alexander Treves, head of investment specialists for Asia-Pacific equities at JPMorgan Asset Management.
Unencumbered by border restrictions in China and Japan, Southeast Asian economies are being supported by the revival of tourism, an industry which contributed 12 percent of their GDP in 2019, the World Travel and Tourism Council said.
Vacation bookings are rising as Thailand, Malaysia and Indonesia offer quarantine-free entry for vaccinated travelers, while Singapore has mostly returned to pre-pandemic life.
“Southeast Asian countries have all reopened with very little travel restrictions, so I think there should be a boost in tourism and consumption activity, especially as we head into the summer travel season,” said David Chao, global market strategist for Invesco Ltd in Hong Kong. “Southeast Asian risk assets look more attractive than North Asian equities.”
The region is an inflation hedge as the war in Ukraine pushes global commodity prices higher. Malaysia is a net oil exporter while Indonesia ships coal, palm oil and natural gas, among other goods, helping drive gains in related shares.
The Jakarta Composite Index is the best-performing major benchmark in Asia this year, up nearly 10 percent and hovering near a record high. The broader Southeast Asia gauge is on track to outperform the MSCI All Country World Index for a second straight quarter.
The outperformance has come despite the Fed kicking off an aggressive campaign of interest rate hikes, something that has weighed on the region’s assets in the past.
The effect of any policy tightening should at least seep through to earnings for financial firms, which make up almost 40 percent of the Southeast Asian benchmark.
Singapore and Indonesia have the region’s largest exposure to financials and “our view is particularly constructive on these two markets for the months ahead,” Deutsche Bank International Private Bank strategists wrote in a note last month.
Southeast Asian stocks also stand out as a haven with expensive US shares hit by rising rates and European stocks under pressure from the impact of the war in Ukraine.
International investors rotating out of China allocations “has indirectly benefited select Southeast Asian markets,” SC Asia global equities portfolio manager Sid Choraria said. “I expect this to continue as long as China concerns persist.”
Apple Inc might make one out of four iPhones in India by 2025, JPMorgan & Chase Co analysts said yesterday, as the tech giant moves some production away from China, amid mounting geopolitical tensions and strict COVID-19 lockdowns in the country. JPMorgan expects Apple to move about 5 percent of iPhone 14 production from late this year to India, which is the second-biggest smartphone market in the world after China. It is also estimating that about 25 percent of all Apple products, including Mac, iPad, Apple Watch and AirPods, would be manufactured outside China by 2025 from 5 percent currently. The US company
HEADING SOUTH: The US company chose Kaohsiung as its site as more customers, partners and start-ups have expanded their operations to the southern city Qualcomm Inc yesterday inaugurated a new innovation center in Kaohsiung as it steps up efforts to foster local start-ups and a 5G technology ecosystem in the city, following in the footsteps of its local partners. The US chip company’s move fits the Kaohsiung City Government’s plan to build a semiconductor supply chain within the next five years, highlighted by Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) first chip plant in the city. TSMC plans to start building the factory by the end of this year, and to start production of 28-nanometer and 7-nanometer chips there in 2024. Qualcomm said it had been
SLUMPING DEMAND: Inventory has climbed by up to 12 weeks as suppliers are under mounting pressure to offload excessive reserves, a TrendForce report said The price of DRAM chips is expected to fall at a steeper rate of 13 to 18 percent next quarter, as high inflation continues to weigh on demand for consumer electronics, causing chip inventories to soar, market researcher TrendForce Corp (集邦科技) said yesterday. The downtrend in DRAM prices could extend from a quarterly decline of 10 to 15 percent in the third quarter, the Taipei-based researcher said. “Demand for consumer electronics continued to stagnate during the third quarter, which used to be a high demand season,” TrendForce said in a statement. “During the quarter, memorychip consumption and shipments both showed quarterly
GlaxoSmithKline (GSK) in July made its consumer health products division a separate entity as it transforms into a world-leading biopharmaceutical company. By uniting science, technology and talent, the company is aiming to prevent and treat diseases with innovative vaccines, specialty pharmaceuticals and general medicines. GSK’s headquarters annually invests NT$192 billion (US$6.07 billion) in research and development, focusing on immune science and advanced technologies in human genetics. GSK’s drug and vaccine development focuses on infectious diseases, HIV, oncology and immunology. Investing in clinical trial research each year, GSK also brings drug development to Taiwan. It cooperates with 17 medical institutes and research